MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$13,475K
Net Income
-$78,763K
Net Profit Margin
-584.51%
EPS
-$0.35
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue, net
13,475
10,785
13,250
14,544
Cost of product revenue
2,011
1,329
1,594
1,774
Research and development
54,138
66,213
50,800
52,358
Selling and marketing
17,276
16,577
12,957
13,088
General and administrative
22,159
20,006
17,660
16,022
Total costs and operating expenses
95,584
104,125
83,011
83,242
Loss from operations
-82,109
-93,340
-69,761
-68,698
Interest income
5,449
6,050
7,345
3,729
Interest expense
2,792
2,777
2,833
3,002
Change in fair value of derivative liabilities
689
1,455
595
-1,447
Other gains (expenses)
-
-
0
-
Total other income (expense), net
3,346
4,728
5,107
-720
Net loss
-78,763
-88,612
-64,654
-69,418
Basic EPS
-0.35
-0.4
-0.29
-0.38
Diluted EPS
-0.35
-0.4
-0.29
-0.38
Basic Average Shares
224,952,428
224,099,410
223,054,473
183,919,808
Diluted Average Shares
224,952,428
224,099,410
223,054,473
183,919,808
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
OCUL Income Statement Sankey Diagram
Sankey diagram visualizing OCUL income statement for the period
Interest income
$5,449K
(57.71%↑ Y/Y)
Change in fair value of
derivative liabilities
$689K
(207.49%↑ Y/Y)
Net loss
-$78,763K
(-16.15%↓ Y/Y)
Total other income
(expense), net
$3,346K
(2034.10%↑ Y/Y)
Interest expense
$2,792K
(-7.43%↓ Y/Y)
Loss from operations
-$82,109K
(-21.39%↓ Y/Y)
Total revenue, net
$13,475K
(0.12%↑ Y/Y)
Total costs and
operating expenses
$95,584K
(17.86%↑ Y/Y)
Research and development
$54,138K
(5.98%↑ Y/Y)
General and
administrative
$22,159K
(54.46%↑ Y/Y)
Selling and marketing
$17,276K
(25.84%↑ Y/Y)
Cost of product
revenue
$2,011K
(3.45%↑ Y/Y)
Buy us a coffee
OCULAR THERAPEUTIX, INC (OCUL)
OCULAR THERAPEUTIX, INC (OCUL)